Noom Med Review
Advertising Disclosure: TelehealthIndex is reader-supported. If you sign up with a
provider through links on this page, we may earn a commission at no extra cost to you.
Commissions never influence our scores or rankings — several of our top-rated providers pay
us nothing. How we score → · Full disclosure →
52.7/100
Noom Med score
Fair · #9 in Weight Loss & GLP-1 Medications · Data as of July 2026
Clinical credibilityWeak
Regulatory & safety recordNotable deductions
Transparency & trustWeak
Access & coverageGood
Customer experienceGood
Value & pricingMixed
Pillar ratings are qualitative summaries of our internal rubric; we do not publish the
point weights. Read the full methodology →
TelehealthIndex scores and rankings are editorial opinions resulting from our selection, weighting, and interpretation of the factors described in our methodology.
What it is
Behavioral-psychology app + medical program; sells BOTH brand and compounded GLP-1s (incl. microdose plans) as of July 2026.
Strengths
- Some insurance coverage
- Available in 46 states
Considerations
- Actively sells compounded semaglutide/tirzepatide incl. 'microdose' plans - the conduct FDA targeted in 2025-26 warning-letter waves (recipient list unpublished)
- $62M auto-renewal class settlement (2022); billing complaints persist
Note: this provider offers compounded medications for one or more services.
Compounded medications are not FDA-approved.
Founded2022
OwnershipPrivate
Availability46 states
InsurancePartial
Money-back guaranteeNot advertised
PricingCompounded plans $199-299/mo incl. med; brand plan ~$99/mo + med cost
Visit Noom Med
We may earn a commission — disclosure.
Alternatives to consider
Data as of July 19, 2026. Scores are editorial opinions reflecting documented business practices, transparency, pricing, access, and nonclinical consumer-service factors — not clinical quality or outcomes. Found an error? Report it →